Bliss GVS Pharma Limited has informed the Exchange about Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma has informed the stock exchange that a draft letter of offer has been submitted in connection with an open offer being made to its public shareholders. The open offer has been triggered under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which means an acquirer has crossed the regulatory threshold for share purchases and must now offer to buy additional shares from the public. The draft letter of offer is a precursor to the final open offer document, which will detail the offer price, the number of shares being bought, and the timeline for shareholders to tender their shares.
Public shareholders of Bliss GVS Pharma will get an opportunity to sell their shares at the offer price once the final letter of offer is dispatched. The stock may see price movement based on how the offer price compares to the current market price, and there could be a potential change in the company's ownership structure depending on the response to the offer.